Prudential Financial
RVMD icon

Prudential Financial’s Revolution Medicines RVMD Stock Holding History

Prudential Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
10,540
-3,142
-23% -$459K ﹤0.01% 1407
2026
Q1 		$1.33M Buy
13,682
+5,425
+66% +$548K ﹤0.01% 1492
2025
Q4 		$658K Sell
8,257
-4,882
-37% -$320K ﹤0.01% 1748
2025
Q3 		$614K Sell
13,139
-34,465
-72% -$1.35M ﹤0.01% 1852
2025
Q2 		$1.75M Buy
47,604
+1,495
+3% +$57.4K ﹤0.01% 1445
2025
Q1 		$1.63M Sell
46,109
-750
-2% -$30.4K ﹤0.01% 1373
2024
Q4 		$2.05M Buy
46,859
+4,645
+11% +$234K ﹤0.01% 1292
2024
Q3 		$1.91M Buy
42,214
+4,855
+13% +$211K ﹤0.01% 1529
2024
Q2 		$1.45M Buy
37,359
+22,400
+150% +$837K ﹤0.01% 1614
2024
Q1 		$482K Buy
14,959
+4,625
+45% +$137K ﹤0.01% 2185
2023
Q4 		$296K Buy
+10,334
New +$248K ﹤0.01% 2326

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Prudential Financial's RVMD Position: Q2 2026 in Review

Prudential Financial reduced its Revolution Medicines (RVMD) stake by 23% in Q2 2026, selling an estimated $459K and leaving 10,540 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Prudential Financial first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.05M in Q4 2024. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Prudential Financial held 10,540 shares of Revolution Medicines worth $1.97M as of Q2 2026.
  • Prudential Financial sold 3,142 Revolution Medicines shares in Q2 2026, an estimated $459K.
  • Revolution Medicines made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1407 holding.
  • Prudential Financial first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • Prudential Financial's Revolution Medicines position peaked at $2.05M in Q4 2024.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.